Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gleave

Showing results (231-240 of 940) with videos related to

Pageof 94
Sort By:
Journal of Cellular Biochemistry|May 15, 1998
Butyrate analogue, isobutyramide, inhibits tumor growth and time to androgen-independent progression in the human prostate LNCaP tumor modelM E Gleave, N Sato, M Sadar, et al.
The Journal of Urology|May 6, 2004
Synergistic antitumor activity by combined treatment with gemcitabine and antisense oligodeoxynucleotide targeting clusterin gene in an intravesical administration model against human bladder cancer kotcc-1 cellsHideaki Miyake, Hiroshi Eto, Isao Hara, et al.
The British Journal of Surgery|February 1, 1986
Randomized study of Corynebacterium parvum adjuvant therapy following surgery for (stage II) malignant melanomaN Thatcher, A Mene, S S Banerjee, et al.
BJU International|November 17, 2007
Measurement of factors influencing the participation of patients with prostate cancer in clinical trials: a Canadian perspectiveB Joyce Davison, Alan So, S Larry Goldenberg, et al.
Clinical Biochemistry|June 24, 2014
Reproducibility and efficiency of serum-derived exosome extraction methodsJosselin Caradec, Geetanjali Kharmate, Elham Hosseini-Beheshti, et al.
Cancer Chemotherapy and Pharmacology|May 3, 2005
Efficacy of an intratumoral controlled release formulation of clusterin antisense oligonucleotide complexed with chitosan containing paclitaxel or docetaxel in prostate cancer xenograft modelsChristopher M K Springate, John K Jackson, Martin E Gleave, et al.
Molecular Urology|November 3, 2001
Acquisition of resistance to Fas-mediated apoptosis by overexpression of clusterin in human renal-cell carcinoma cellsH Miyake, S Hara, T Zellweger, et al.
The British Journal of Surgery|November 1, 1970
Steroid metabolism by human breast tumoursE N Gleave, D Jones, E H Cameron, et al.
The Biochemical Journal|March 1, 1970
Steroid metabolism by human breast tumoursD Jones, E H Cameron, K Griffiths, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|May 20, 2014
Comparison of open and robotic-assisted prostatectomy: The University of British Columbia experienceLouis-Olivier Gagnon, S Larry Goldenberg, Kenny Lynch, et al.
Pageof 94

Showing results (231-240 of 940) with videos related to

Sort By:
Pageof 94
Journal of Cellular Biochemistry|May 15, 1998
Butyrate analogue, isobutyramide, inhibits tumor growth and time to androgen-independent progression in the human prostate LNCaP tumor modelM E Gleave, N Sato, M Sadar, et al.
The Journal of Urology|May 6, 2004
Synergistic antitumor activity by combined treatment with gemcitabine and antisense oligodeoxynucleotide targeting clusterin gene in an intravesical administration model against human bladder cancer kotcc-1 cellsHideaki Miyake, Hiroshi Eto, Isao Hara, et al.
The British Journal of Surgery|February 1, 1986
Randomized study of Corynebacterium parvum adjuvant therapy following surgery for (stage II) malignant melanomaN Thatcher, A Mene, S S Banerjee, et al.
BJU International|November 17, 2007
Measurement of factors influencing the participation of patients with prostate cancer in clinical trials: a Canadian perspectiveB Joyce Davison, Alan So, S Larry Goldenberg, et al.
Clinical Biochemistry|June 24, 2014
Reproducibility and efficiency of serum-derived exosome extraction methodsJosselin Caradec, Geetanjali Kharmate, Elham Hosseini-Beheshti, et al.
Cancer Chemotherapy and Pharmacology|May 3, 2005
Efficacy of an intratumoral controlled release formulation of clusterin antisense oligonucleotide complexed with chitosan containing paclitaxel or docetaxel in prostate cancer xenograft modelsChristopher M K Springate, John K Jackson, Martin E Gleave, et al.
Molecular Urology|November 3, 2001
Acquisition of resistance to Fas-mediated apoptosis by overexpression of clusterin in human renal-cell carcinoma cellsH Miyake, S Hara, T Zellweger, et al.
The British Journal of Surgery|November 1, 1970
Steroid metabolism by human breast tumoursE N Gleave, D Jones, E H Cameron, et al.
The Biochemical Journal|March 1, 1970
Steroid metabolism by human breast tumoursD Jones, E H Cameron, K Griffiths, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|May 20, 2014
Comparison of open and robotic-assisted prostatectomy: The University of British Columbia experienceLouis-Olivier Gagnon, S Larry Goldenberg, Kenny Lynch, et al.
Pageof 94